Table 2 Surgical and adjuvant treatment characteristics according to actually received study group (ALND vs SLNB)
Test | Classes | All (n = 963) | ALND (n = 443) | SLNB (n = 520) | p-value |
|---|---|---|---|---|---|
Breast surgery Type | Mastectomy | 170 (17.65) | 77 (17.38) | 93 (17.88) | 0.8383 |
Conservative | 793 (82.35) | 366 (82.62) | 427 (82.12) | ||
Radiotherapy | No | 38 (4.07) | 19 (4.45) | 19 (3.75) | 0.5885 |
Yes | 896 (95.93) | 408 (95.55) | 488 (96.25) | ||
Chemotherapy | No | 282 (29.59) | 126 (28.70) | 156 (30.35) | 0.3482 |
Neoadjuvant | 27 (2.83) | 16 (3.64) | 11 (2.14) | ||
Adjuvant | 644 (67.58) | 297 (67.65) | 347 (67.51) | ||
Endocrine therapy | No | 78 (10.39) | 30 (8.72) | 48 (11.79) | 0.1691 |
Yes | 673 (89.61) | 314 (91.28) | 359 (88.21) | ||
Trastuzumab | No | 578 (85.76) | 261 (85.02) | 317 (86.38) | 0.6149 |
Yes | 96 (14.24) | 46 (14.98) | 50 (13.62) |